Private Ocean’s BioMarin Pharmaceuticals BMRN Stock Holding History

Private Ocean’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$119K	Buy	+1,450	New	+$121K	0.01%	191
2024 Q1	–	Sell	-1,450	Closed	-$140K	–	487
2023 Q4	$140K	Buy	+1,450	New	+$128K	0.01%	172
2023 Q2	–	Sell	-1,450	Closed	-$141K	–	585
2023 Q1	$141K	Hold	1,450	–	–	0.02%	152
2022 Q4	$150K	Hold	1,450	–	–	0.02%	136
2022 Q3	$122K	Buy	+1,450	New	+$129K	0.02%	153
2022 Q2	–	Sell	-1,450	Closed	-$112K	–	490
2022 Q1	$112K	Hold	1,450	–	–	0.01%	165
2021 Q4	$128K	Hold	1,450	–	–	0.02%	166
2021 Q3	$112K	Buy	+1,450	New	+$114K	0.01%	172
2021 Q2	–	Sell	-1,450	Closed	-$109K	–	533
2021 Q1	$109K	Sell	1,450 -101	-7%	-$8.25K	0.02%	167
2020 Q4	$136K	Buy	1,551 +101	+7%	+$8.01K	0.03%	134
2020 Q3	$110K	Hold	1,450	–	–	0.03%	149
2020 Q2	$178K	Hold	1,450	–	–	0.04%	103
2020 Q1	$122K	Buy	+1,450	New	+$125K	0.03%	121
2019 Q4	–	Sell	-1,450	Closed	-$98K	–	509
2019 Q3	$98K	Buy	+1,450	New	+$112K	0.02%	153

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Private Ocean's BMRN Position: Q2 2024 in Review

Private Ocean opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2024: 1,450 shares worth $119K. The stake represents 0.01% of the portfolio and ranks #191 among its holdings. This is a return to the name: Private Ocean previously reported a position in BMRN as recently as Q4 2023.

Private Ocean first reported a position in BMRN in Q3 2019 and has held it in 14 quarters since. The position peaked at $178K in Q2 2020. 558 funds tracked by Wall St. Rank hold BMRN as of Q2 2024.

Private Ocean held 1,450 shares of BioMarin Pharmaceuticals worth $119K as of Q2 2024.
BioMarin Pharmaceuticals was a new Private Ocean position in Q2 2024.
BioMarin Pharmaceuticals made up 0.01% of Private Ocean's portfolio in Q2 2024, its #191 holding.
Private Ocean first reported a position in BioMarin Pharmaceuticals in Q3 2019 and has held it in 14 quarters since.
Private Ocean's BioMarin Pharmaceuticals position peaked at $178K in Q2 2020.
558 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2024.

Based on Private Ocean's 13F filing for Q2 2024, filed 30 Jul 2024.